Zofran (Ondasetron): Difference between revisions
Jump to navigation
Jump to search
Danesthesia (talk | contribs) No edit summary Tags: Manual revert Reverted Visual edit |
Danesthesia (talk | contribs) No edit summary Tags: Manual revert Visual edit |
||
| Line 4: | Line 4: | ||
{{infobox drug | {{infobox drug | ||
| drug_name = | | drug_name = zofranx | ||
| image = zofran.png | | image = zofran.png | ||
| caption = zofran 4 mg tablet | | caption = zofran 4 mg tablet | ||
Revision as of 21:13, 17 May 2023
Zofran (Ondasetron)
| drug name: | zofranx |
|---|---|
| image: | zofran.png |
| caption: | zofran 4 mg tablet |
| type: | antiemetic |
| routes of administration: | oral, intravenous, intramuscular |
| metabolism: | liver (CYP2D6, CYP3A4) |
| legal status: | prescription only |
| bioavailability: | sss |
| protein bound: | 70-76% |
| elimination half-life: | 3-6 hours |
| excretion: | kidney (60%), feces (40%) |
Zofran (ondansetron) is an antiemetic medication used to prevent nausea and vomiting, particularly in the field of anesthesia. It is a selective 5-HT3 receptor antagonist, which works by blocking the action of serotonin in the brain and the gastrointestinal tract.
Route of administration
- Oral: Disintegrating tablets, film-coated tablets, and oral solution
- Intravenous: Injection
- Intramuscular: Injection
Dose
For anesthesia-related nausea and vomiting:
- Adult:
* Oral: 16 mg before anesthesia induction * Intravenous: 4 mg before anesthesia induction or immediately before/during/after surgery
- Pediatric:
* Oral: 4 mg for children aged 4-11 years, 30-60 minutes before surgery * Intravenous: 0.1 mg/kg (up to 4 mg) for children aged 1 month-12 years, immediately before/during/after surgery
Half-life
- The elimination half-life of ondansetron is approximately 3-6 hours.
Expected time to work
- Oral: Onset of action is approximately 30 minutes to 2 hours.
- Intravenous: Onset of action is approximately 5-30 minutes.
Use in anesthesia
Zofran is commonly used in anesthesia to:
- Prevent postoperative nausea and vomiting (PONV)
- Prevent nausea and vomiting induced by chemotherapy
- Prevent nausea and vomiting associated with radiation therapy
Side effects
- Headache
- Fatigue
- Constipation
- Diarrhea
- Dizziness
Contraindications
- Hypersensitivity to ondansetron or any component of the formulation
- Concomitant use with apomorphine
- Patients with congenital long QT syndrome
Drug interactions
- Serotonin syndrome risk may increase when combined with other serotonergic agents (e.g., SSRIs, SNRIs, TCAs, MAOIs, triptans)
References